Intermittent fasting and hormonal regulation: Pathways to improved metabolic health
On the other hand, Al-Aly points out no medicine is risk-free
healthcare providers who can evaluate your health history and, if appropriate, prescribe a personalized treatment plan
however, those who persisted with the medication coverage experienced weight losses comparable with those shown in corresponding clinical trials. And in a paper published in 2023, researchers found that while significant weight loss was achievable with GLP-1s among type 2 diabetes patients, the average weight reduction was relatively modest, 2.2% after 72 weeks of being on the medications
Its primary studied outcome is craving reduction, not direct weight loss
Within 8 weeks, energy improved, nausea resolved, and DEXA confirmed preservation of lean mass